Experimental Hematology
Volume 38, Issue 7 , Pages 557-563 , July 2010

Derivation of multipotent progenitors from human circulating CD14+ monocytes

  • Noriyuki Seta
    • ,
  • Masataka Kuwana

      Affiliations

    • Corresponding Author InformationOffprint requests to: Masataka Kuwana, M.D., Ph.D., Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

Received 28 February 2010 ,Revised 28 February 2010 ,Accepted 24 March 2010.

References 

  1. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. Stem Cells. 2004;22:487–500
  2. Masuya M, Drake CJ, Fleming PA, et al. Hematopoietic origin of glomerular mesangial cells. Blood. 2003;101:2215–2218
  3. Sera Y, LaRue AC, Moussa O, et al. Hematopoietic stem cell origin of adipocytes. Exp Hematol. 2009;37:1108–1120
  4. Fujita J, Mori M, Kawada H, et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells. 2007;25:2750–2759
  5. Miyamoto T, Ohneda O, Arai F, et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood. 2001;98:2544–2554
  6. Servet-Delprat C, Arnaud S, Jurdic P, et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol. 2002;3:15–25
  7. Naito M, Hasegawa G, Takahashi K. Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech. 1997;39:350–364
  8. Zhao Y, Glesne D, Huberman E, et al. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A. 2003;100:2426–2431
  9. Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res. 2005;97:314–322
  10. Kuwana M, Okazaki Y, Kodama H, et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol. 2003;74:833–845
  11. Takeda Y, Mori T, Imabayashi H, et al. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?. J Gene Med. 2004;6:833–845
  12. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147
  13. Kodama H, Inoue T, Watanabe R, et al. Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes. Stem Cell Dev. 2005;14:676–686
  14. Kodama H, Inoue T, Watanabe R, et al. Neurogenic potential of progenitors derived from human circulating CD14+ monocytes. Immunol Cell Biol. 2006;84:209–217
  15. Kuwana M, Okazaki Y, Kodama H, Satoh T, Kawakami Y, Ikeda Y. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells. 2006;24:2733–2743
  16. Seta N, Okazaki Y, Kuwana M. Human circulating monocytes can express receptor activator of nuclear factor-κB ligand and differentiate into functional osteoclasts without exogenous stimulation. Immunol Cell Biol. 2008;86:453–459
  17. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71–81
  18. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest. 2007;117:549–556
  19. Barth PJ, Westhoff CC. CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther. 2007;2:221–227
  20. Chambers I, Colby D, Robertson M, et al. Functional expression cloning of Nanog a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643–655
  21. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001;19:271–278
  22. Makino K, Kuwahara H, Masuko N, et al. Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene. 1997;14:2425–2453
  23. Bohil AB, Robertson BW, Cheney RE. Myosin-X is a molecular motor that functions in filopodia formation. Proc Natl Acad Sci U S A. 2006;103:12411–12416
  24. Zhang H, Berg JS, Li Z, et al. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nat Cell Biol. 2004;6:523–531
  25. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res. 2000;9:841–848
  26. Kucher C, Xu X, Pasha T, Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol. 2005;32:484–490
  27. Bardin T, Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol. 2010;22:54–58
  28. Mattoli S, Bellini A, Schmidt M. The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr Stem Cell Res Ther. 2009;4:266–280

PII: S0301-472X(10)00106-2

doi: 10.1016/j.exphem.2010.03.015

Experimental Hematology
Volume 38, Issue 7 , Pages 557-563 , July 2010

Article Tools

* Image Usage & Resolution